Table 5.
n=22 | Percentage | |
Objective response* † | 10 | 45 |
Complete response | 0 | 0 |
Partial response | 10 | 45 |
Stable disease | 6 | 27 |
Progressive disease | 5 | 23 |
Not evaluable | 1 | 5 |
*Responses were evaluated in patients with postsurgical recurrence and advanced non-small cell lung cancer with target lesions.
†95% CI 24.4% to 67.8%.